Galvus (vildagliptin) - DPP-IV Inhibitor / Oral Antidiabetic Agent

Management of type 2 diabetes requires the maintenance of good glycaemic control together with tight control of blood lipid levels and blood pressure.


		Next»

| 1 | 2 | 3 | 4 | 5 |

Browse More Images - Return to Project